Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Vafiadis

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Alimentary Pharmacology & Therapeutics|February 19, 2009
Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort studyE K Manesis, G V Papatheodoridis, G Touloumi, et al.
Hepatology (Baltimore, Md.)|July 1, 1999
Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP)V Carreño, P Marcellin, S Hadziyannis, et al.
Journal of Viral Hepatitis|July 22, 2014
Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohortG V Papatheodoridis, S Manolakopoulos, G Touloumi, et al.
Journal of Viral Hepatitis|May 20, 2003
A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1N C Tassopoulos, D Tsantoulas, M Raptopoulou, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Alimentary Pharmacology & Therapeutics|February 19, 2009
Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort studyE K Manesis, G V Papatheodoridis, G Touloumi, et al.
Hepatology (Baltimore, Md.)|July 1, 1999
Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP)V Carreño, P Marcellin, S Hadziyannis, et al.
Journal of Viral Hepatitis|July 22, 2014
Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohortG V Papatheodoridis, S Manolakopoulos, G Touloumi, et al.
Journal of Viral Hepatitis|May 20, 2003
A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1N C Tassopoulos, D Tsantoulas, M Raptopoulou, et al.
Pageof 2